Beacon Capital Management LLC (Tennessee)’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,905
Closed -$50.4K 464
2025
Q2
$50.4K Hold
23,905
0.01% 331
2025
Q1
$29.2K Hold
23,905
﹤0.01% 407
2024
Q4
$30.8K Hold
23,905
﹤0.01% 386
2024
Q3
$65.7K Hold
23,905
0.01% 278
2024
Q2
$54K Hold
23,905
0.01% 274
2024
Q1
$57.1K Hold
23,905
0.01% 272
2023
Q4
$45.9K Buy
23,905
+11,300
+90% +$21.9K 0.01% 234
2023
Q3
$18.2K Hold
12,605
﹤0.01% 426
2023
Q2
$18.2K Hold
12,605
﹤0.01% 426
2023
Q1
$26.5K Hold
12,605
0.01% 321
2022
Q4
$14.2K Buy
+12,605
New +$16.8K ﹤0.01% 433

Other funds holding GALT